Nixon Peabody
Bank of America
You are here:  Home  >  Biotech  >  Current Article

Amgen’s stock climbs after announcing Otezla acquisition

By   /   Monday, August 26th, 2019  /   Comments Off on Amgen’s stock climbs after announcing Otezla acquisition

    Print       Email
A statue of Amgen co-founder William K. Bowes Jr. stands watch over the Thousand Oaks campus. Story updated at 4 p.m. Aug. 26: Shares for the region’s biotech heavyweight popped 3 percent Aug. 26 after it announced plans to add a psoriasis drug to its portfolio. Amgen said it will spend $13.4 billion in cash…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Deckers beats expectations with rising sales, shrinking losses in second quarter

Read More →